140 related articles for article (PubMed ID: 26695422)
1. Synthesis and the Evaluations in vitro Antiplatelet Aggregation Activities of 4-Ethoxyisophthalamides.
Liu XJ; Shi TE; Wang X; Wei TT; Meng X
Cardiovasc Hematol Agents Med Chem; 2015; 13(2):124-8. PubMed ID: 26695422
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and in vitro activities on anti-platelet aggregation of 4-methoxybenzene-1,3-isophthalamides.
Liu XJ; Shi XX; Zhong YL; Liu N; Liu K
Bioorg Med Chem Lett; 2012 Nov; 22(21):6591-5. PubMed ID: 23010272
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, in vitro cytotoxicity and biological evaluation of twenty novel 1,3-benzenedisulfonyl piperazines as antiplatelet agents.
Liu XJ; Wang Y; Wang X; Zhang ZH
Bioorg Med Chem; 2021 Sep; 46():116390. PubMed ID: 34500186
[TBL] [Abstract][Full Text] [Related]
4. [In vitro study of the mechanism of the platelet anti-aggregant action of picotamide (G 137)].
Berrettini M; De Cunto M; Romanelli A; Volpato I; Orzalesi G; Nenci GG
Boll Soc Ital Biol Sper; 1983 Mar; 59(3):309-15. PubMed ID: 9704127
[No Abstract] [Full Text] [Related]
5. Design, Synthesis and Evaluation of Antiplatelet Aggregation Inhibitory Activities of the Analogs of Picotamide.
Liu XJ
Cardiovasc Hematol Agents Med Chem; 2015 Sep; ():. PubMed ID: 26362278
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of 4-methoxy-3-arylamido-N-(substitutedphenyl)benzamide derivatives as potential antiplatelet agents.
Liu X; Chen X; Qiu K; Zhang Z
Arch Pharm (Weinheim); 2020 Feb; 353(2):e1900231. PubMed ID: 31808975
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agents.
Liu G; Xu J; Chen N; Zhang S; Ding Z; Du H
Eur J Med Chem; 2012 Jul; 53():114-23. PubMed ID: 22531380
[TBL] [Abstract][Full Text] [Related]
8. [Design, synthesis of novel N, N'-bis-(halogenophenyl)-4- methoxybenzene-1, 3-disulfonamides and evaluation of their anti-platelet aggregation activity].
Li GA; Wang X; Meng X; Lin YB; Li X; Liu XJ
Yao Xue Xue Bao; 2015 Feb; 50(2):185-90. PubMed ID: 25975026
[TBL] [Abstract][Full Text] [Related]
9. Derivatives of 7-amino-1,2,3,4-tetrahydroisoquinoline and isophthalic acids as novel fibrinogen receptor antagonists.
Malovichko OL; Petrus AS; Krysko AA; Kabanova TA; Andronati SA; Karaseva TL; Kiriyak AV
Bioorg Med Chem Lett; 2006 Oct; 16(20):5294-7. PubMed ID: 16919941
[TBL] [Abstract][Full Text] [Related]
10. New 1H-pyrazole-4-carboxamides with antiplatelet activity.
Rehse K; Kotthaus J; Khadembashi L
Arch Pharm (Weinheim); 2009 Jan; 342(1):27-33. PubMed ID: 19051198
[TBL] [Abstract][Full Text] [Related]
11. Studies on in vitro effect of picotamide on human platelet aggregation in platelet-rich plasma and whole blood.
Anfossi G; Parisi S; Russo I; Mularoni EM; Massucco P; Cavalot F; Mattiello L; Trovati M
Thromb Res; 1995 Mar; 77(5):399-410. PubMed ID: 7778055
[TBL] [Abstract][Full Text] [Related]
12. Effect of picotamide and aspirin, combined or alone, on platelet aggregation in patients with cerebral infarction.
D'Andrea G; Perini F; Hasselmark L; Alecci M; Cananzi AR
Funct Neurol; 1995; 10(2):91-8. PubMed ID: 7557557
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis and Pharmacological Evaluation of Novel Piperlongumine derivatives as Potential Antiplatelet Aggregation Candidate.
Wang Y; Wang J; Li J; Zhang Y; Huang W; Zuo J; Liu H; Xie D; Zhu P
Chem Biol Drug Des; 2016 Jun; 87(6):833-40. PubMed ID: 26706668
[TBL] [Abstract][Full Text] [Related]
14. [In vitro study of the effects of various 4-hydroxyisophthalic acid derivatives on human platelet aggregation].
De Cunto M; Berrettini M; Parise P; De Regis M; Orzalesi G; Nenci GG
Boll Soc Ital Biol Sper; 1983 Mar; 59(3):302-8. PubMed ID: 9704126
[No Abstract] [Full Text] [Related]
15. Design, synthesis and evaluation of 1,4-benzodioxine derivatives as novel platelet aggregation inhibitors.
Xie Z; Zhao L; Ding X; Kong Y; Li Z
Future Med Chem; 2018 Feb; 10(4):367-378. PubMed ID: 29380625
[TBL] [Abstract][Full Text] [Related]
16. Rational Design and Synthesis of 1-(Arylideneamino)-4-aryl-1H-imidazole-2-amine Derivatives as Antiplatelet Agents.
Amidi S; Esfahanizadeh M; Tabib K; Soleimani Z; Kobarfard F
ChemMedChem; 2017 Jun; 12(12):962-971. PubMed ID: 28494138
[TBL] [Abstract][Full Text] [Related]
17. In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production.
Cattaneo M; Tenconi PM; Lecchi A; Mannucci PM
Thromb Res; 1991 Jun; 62(6):717-24. PubMed ID: 1926062
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro anti-platelet aggregation activities of 2-methoxy-5-arylamido-N-(pyridin-3-yl-methyl)benzamides.
Wang Y; Wang X; Chen X; Liu X
Arch Pharm (Weinheim); 2019 Jan; 352(1):e1800257. PubMed ID: 30500077
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and inhibitory activities on platelet aggregation of some flavonoid analogues.
Göker H; Tunçbilek M; Leoncini G; Buzzi E; Mazzei M; Rolland Y; Ertan R
Arzneimittelforschung; 1995 Feb; 45(2):150-5. PubMed ID: 7710437
[TBL] [Abstract][Full Text] [Related]
20. New platelet aggregation inhibitors based on pyridazinone moiety.
Costas T; Costas-Lago MC; Vila N; Besada P; Cano E; Terán C
Eur J Med Chem; 2015 Apr; 94():113-22. PubMed ID: 25757094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]